Roche Diagnostics Operations, Inc.

Roche Diabetes Care, Inc.

Roche Diagnostics Gmbh

F. Hoffmann-la Roche Ag

Robert Lorenz

Ulrich Porsch

Karl Miltner

Clemens Knapp

Detlef Thym

Rudolf Pachl

Karl Werner

Hartmut Merdes

Kai-Oliver Schwenker

Otto Gaa

Wolfgang Heck

Gertrud Albrecht

Stefan Sieber

Udo Manser

Peter Stephan

Stefan Schosnig

Frank Rueckert

Ulrich Kehr

Andree Treinzen

Wofgang-Reinhold Knappe

Beda Steinacher

There is provided a test method for analysing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.

Test method and test drive for analysing a body fluid

There is provided a test method for analyzing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.

Test method and test device for analysing a body fluid

Methods are provided for photometrically determining/detecting sample application to an analytical test element for use with a blood glucose measuring device, where the method includes obtaining a sequence of reflectance readings from the test element with the measuring device, including a blank value prior to sample application, and then monitoring changes of the reflectance readings from the test element with respect to a sample application condition defined by a limit for a reflectance decrease or a reflectance threshold. The methods also can include adjusting the sample application condition in accordance with a drift correction and can include determining an analyte concentration in the body fluid sample. In addition, photometric blood glucose measuring devices are provided that incorporate the methods disclosed herein.

Methods and devices for photometrically determining sample application on test elements

A medical system and method to operating the medical system is presented. A patient storage element is assigned to a patient comprising identification information identifying the patient. A medical device has a contaminating patient application. A medical device storage element on the medical device comprises use information. A clearing device receives the identification information from the patient storage element and the use information from the medical device storage element and analyzes the use information. If in analyzing the use information it is found that application of the medical device to the patient is allowed, a clearance signal is outputted. If in analyzing the use information it is found that application of the medical device to the patient is not allowed, the identification information is analyzed. If in analyzing the identification information it is found that application of the medical device to the patient is allowed, a clearance signal is outputted.

Medical system and method for operating a medical system

There is provided a test method for analysing a body fluid in which a test tape is used in a test device in order to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. In order to increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.

The invention relates to a system for testing a sample of bodily fluid, comprising a carrier band, which carries a plurality of consumable elements, wherein one end of the carrier band is attached to a wind-up device for winding the carrier band, together with used consumable elements, onto a reel for the band transport, and comprising a display for displaying information regarding the supply of yet unused consumable elements of the carrier band. According to the invention, it is provided that information regarding the supply of yet unused consumable elements of the carrier band is obtained from an angle of rotation and from a band transport length by which the carrier band is moved with a rotation of the reel about said angle of rotation.

System for determining a number of unused consumable elements for testing a bodily fluid sample

The invention relates to an analysis system for the photometric determination of an analyte in a body fluid, having an analysis device and a test carrier. The test carrier has an evaluation zone in which a photometrically detectable change takes place as the result of a reaction of a sample of the body fluid which contacts the test carrier with a reagent contained in the test carrier. The analysis device comprises an optical emitter for emitting light onto the evaluation zone, an optical receiver for receiving light from the evaluation zone and for generating a measurement signal corresponding to the received light, and a measurement and evaluation device with a measuring unit and an evaluating unit. The measurement signal is amplified and digitalized in the measuring unit. In the evaluating unit, the concentration value is determined from the digitalized measurement signal. In the evaluating unit, a control value of a control parameter is detected at one detection point during the processing after the calculation step. An error in the measurement and evaluation device is recognized if the deviation of the control value from the expected value exceeds a predefined threshold value.

Analysis system for the photometric determination of an analyte in a body fluid

A test tape unit with a flexible carrier tape that can be wound forwardly by a tape drive is provided. The carrier tape includes a plurality of analytical test fields for the application of body fluid that are each applied in an associated tape section. Each tape section has a plurality of position markers for different functional positions that can be scanned by means of a tape sensor and can thereby be individually identified by measured quantity.

Test tape unit and test tape device

Glucose analysis instrument for diabetics, comprising a measuring device for determining glucose concentration values, a displaying device for displaying glucose concentration values, a signaling device for generating a reminder signal, and a control and evaluation device that comprises a processor and a data memory and is used to determine reminder times at which the signaling device is actuated. Event data are stored in the data memory, the event data containing information on events occurring in the life of a user of the glucose analysis instrument and on the time of occurrence of such events. The reminder times are determined by means of a reminder time determination algorithm taking into consideration event data from at least one previous day.

Glucose analysis instrument

The present invention concerns a diagnostic test carrier for the determination of an analyte from whole blood with the aid of a reagent system contained in the carrier which includes a colour forming reagent with a test field which has a sample application side onto which the blood sample is applied and a detection side on which an optically detectable change takes place as a result of the reaction of analyte with the reagent system and which is constructed in such a way that erythrocytes present in the sample do not reach the detection side, which is characterized in that the test field comprises a transparent foil onto which a first and a second film layer are applied on top of one another and wherein the first layer located on the transparent foil scatters light considerably less in a wet state than the overlying second layer and wherein the side of the foil on which the first layer is applied which is opposite to the foil side is the detection side and the side of the second layer which is opposite to the side with which the second layer rests on the first is the sample application side. In addition the invention concerns a method for the determination of an analyte from whole blood with the aid of a diagnostic test carrier according to the invention.

Growing community of inventors

Worms, Germany

Robert Lorenz